AAV1-FS344: Phase I/IIa data

A dose-escalation Phase I/IIa trial in 6 patients with Becker muscular dystrophy showed that AAV1-FS344 given by direct

Read the full 180 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE